Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Changes in Availability of ENDS: 2019-2020, U.S.
Gammon DG, Rogers T, Coats EM, Nonnemaker JM, Spinks JG, Valverde R, Snyder K, Ross AM, Xu X, Liu ST. Gammon DG, et al. Among authors: valverde r. Am J Prev Med. 2022 Dec;63(6):1017-1025. doi: 10.1016/j.amepre.2022.07.006. Epub 2022 Sep 13. Am J Prev Med. 2022. PMID: 36109309
Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2.
Schönherr H, Ayaz P, Taylor AM, Casaletto JB, Touré BB, Moustakas DT, Hudson BM, Valverde R, Zhao S, O'Hearn PJ, Foster L, Sharon DA, Garfinkle S, Giordanetto F, Lescarbeau A, Kurukulasuriya R, Gerami-Moayed N, Maglic D, Bruderek K, Naik G, Gunaydin H, Mader MM, Boezio AA, McLean TH, Chen R, Wang Y, Shaw DE, Watters J, Bergstrom DA. Schönherr H, et al. Among authors: valverde r. Proc Natl Acad Sci U S A. 2024 Feb 6;121(6):e2317756121. doi: 10.1073/pnas.2317756121. Epub 2024 Feb 1. Proc Natl Acad Sci U S A. 2024. PMID: 38300868 Free PMC article.
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia.
Varkaris A, Pazolli E, Gunaydin H, Wang Q, Pierce L, Boezio AA, Bulku A, DiPietro L, Fridrich C, Frost A, Giordanetto F, Hamilton EP, Harris K, Holliday M, Hunter TL, Iskandar A, Ji Y, Larivée A, LaRochelle JR, Lescarbeau A, Llambi F, Lormil B, Mader MM, Mar BG, Martin I, McLean TH, Michelsen K, Pechersky Y, Puente-Poushnejad E, Raynor K, Rogala D, Samadani R, Schram AM, Shortsleeves K, Swaminathan S, Tajmir S, Tan G, Tang Y, Valverde R, Wehrenberg B, Wilbur J, Williams BR, Zeng H, Zhang H, Walters WP, Wolf BB, Shaw DE, Bergstrom DA, Watters J, Fraser JS, Fortin PD, Kipp DR. Varkaris A, et al. Among authors: valverde r. Cancer Discov. 2024 Feb 8;14(2):240-257. doi: 10.1158/2159-8290.CD-23-0944. Cancer Discov. 2024. PMID: 37916956 Free PMC article.
Adaptation of sea turtles to climate warming: Will phenological responses be sufficient to counteract changes in reproductive output?
Fuentes MMPB, Santos AJB, Abreu-Grobois A, Briseño-Dueñas R, Al-Khayat J, Hamza S, Saliba S, Anderson D, Rusenko KW, Mitchell NJ, Gammon M, Bentley BP, Beton D, Booth DTB, Broderick AC, Colman LP, Snape RTE, Calderon-Campuzano MF, Cuevas E, Lopez-Castro MC, Flores-Aguirre CD, Mendez de la Cruz F, Segura-Garcia Y, Ruiz-Garcia A, Fossette S, Gatto CR, Reina RD, Girondot M, Godfrey M, Guzman-Hernandez V, Hart CE, Kaska Y, Lara PH, Marcovaldi MAGD, LeBlanc AM, Rostal D, Liles MJ, Wyneken J, Lolavar A, Williamson SA, Manoharakrishnan M, Pusapati C, Chatting M, Mohd Salleh S, Patricio AR, Regalla A, Restrepo J, Garcia R, Santidrián Tomillo P, Sezgin C, Shanker K, Tapilatu F, Turkozan O, Valverde RA, Williams K, Yilmaz C, Tolen N, Nel R, Tucek J, Legouvello D, Rivas ML, Gaspar C, Touron M, Genet Q, Salmon M, Araujo MR, Freire JB, Castheloge VD, Jesus PR, Ferreira PD, Paladino FV, Montero-Flores D, Sozbilen D, Monsinjon JR. Fuentes MMPB, et al. Among authors: valverde ra. Glob Chang Biol. 2024 Jan;30(1):e16991. doi: 10.1111/gcb.16991. Epub 2023 Oct 31. Glob Chang Biol. 2024. PMID: 37905464
RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations.
Subbiah V, Sahai V, Maglic D, Bruderek K, Touré BB, Zhao S, Valverde R, O'Hearn PJ, Moustakas DT, Schönherr H, Gerami-Moayed N, Taylor AM, Hudson BM, Houde DJ, Pal D, Foster L, Gunaydin H, Ayaz P, Sharon DA, Goyal L, Schram AM, Kamath S, Sherwin CA, Schmidt-Kittler O, Jen KY, Ricard F, Wolf BB, Shaw DE, Bergstrom DA, Watters J, Casaletto JB. Subbiah V, et al. Among authors: valverde r. Cancer Discov. 2023 Sep 6;13(9):2012-2031. doi: 10.1158/2159-8290.CD-23-0475. Cancer Discov. 2023. PMID: 37270847 Free PMC article.
Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trial.
Moniche F, Cabezas-Rodriguez JA, Valverde R, Escudero-Martinez I, Lebrato-Hernandez L, Pardo-Galiana B, Ainz L, Medina-Rodriguez M, de la Torre J, Escamilla-Gomez V, Ortega-Quintanilla J, Zapata-Arriaza E, de Albóniga-Chindurza A, Mancha F, Gamero MA, Perez S, Espinosa-Rosso R, Forero-Diaz L, Moya M, Piñero P, Calderón-Cabrera C, Nogueras S, Jimenez R, Martin V, Delgado F, Ochoa-Sepúlveda JJ, Quijano B, Mata R, Santos-González M, Carmona-Sanchez G, Herrera C, Gonzalez A, Montaner J. Moniche F, et al. Among authors: valverde r. Lancet Neurol. 2023 Feb;22(2):137-146. doi: 10.1016/S1474-4422(22)00526-9. Lancet Neurol. 2023. PMID: 36681446 Clinical Trial.
163 results